RNA-based therapeutics hold great promise for treating diseases and lipid nanoparticles (LNPs) represent the most advanced platform for RNA delivery. However, the fate of the LNP-mRNA after endosome-engulfing and escape from the autophagy-lysosomal pathway remains unclear. To investigate this, mRNA (encoding human erythropoietin) was delivered to cells using LNPs, which shows, for the first time, a link between LNP-mRNA endocytosis and its packaging into extracellular vesicles (endo-EVs: secreted after the endocytosis of LNP-mRNA). Endosomal escape of LNP-mRNA is dependent on the molar ratio between ionizable lipids and mRNA nucleotides. Our results show that fractions of ionizable lipids and mRNA (1:1 molar ratio of hEPO mRNA nucleotides:ionizable lipids) of endocytosed LNPs were detected in endo-EVs. Importantly, these EVs can protect the exogenous mRNA during in vivo delivery to produce human protein in mice, detected in plasma and organs. Compared to LNPs, endo-EVs cause lower expression of inflammatory cytokines.
BackgroundThis study aimed to profile levels of blood cells and serum cytokines during afebrile and febrile phases of periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome to advance pathophysiological understanding of this pediatric disease.MethodsA cohort of patients with a median age of 4.9 years experiencing 'typical PFAPA' episodes participated in this study. Blood cells and serum cytokines were analyzed by CBC analysis and multiplex ELISA.ResultsOscillations in the concentration of blood cells during the afebrile and febrile phases of typical PFAPA syndrome were observed; novel findings include increased monocytes and decreased eosinophils during a febrile episode and increased thrombocytes in the afebrile interval. Relatively modest levels of pro-inflammatory cytokines were present in sera. IFNγ-induced cytokine IP10/CXCL10 was increased after the onset of fever while T cell-associated cytokines IL7 and IL17 were suppressed during afebrile and febrile periods.ConclusionsIdentification of dysregulated blood cells and serum cytokines is an initial step towards the identification of biomarkers of PFAPA disease and/or players in disease pathogenesis. Future investigations are required to conclusively discern which mediators are associated specifically with PFAPA syndrome.
Formyl peptide receptor 2 (FPR2) is a G protein-coupled pattern recognition receptor sensing both mitochondrial-and bacterialderived formylated peptides, including the PSMa toxins secreted by community-associated methicillin-resistant Staphylococcus aureus strains. Similar to many other FPR2 agonistic peptides, nanomolar concentrations of both PSMa2 and PSMa3 activate neutrophils to increase the cytosolic concentration of Ca 2+ and release NADPH oxidase-derived reactive oxygen species. In addition, the PSMa peptides induce FPR2 homologous desensitization, actin polymerization, and neutrophil reactivation through a receptor cross-talk mechanism. However, in contrast to conventional FPR2 agonistic peptides, including the host-derived formyl peptide MCT-ND4, we found that the PSMa peptides lacked the ability to recruit b-arrestin and induce neutrophil chemotaxis, supporting the previous notion that b-arrestin translocation is of importance for cell migration. Despite the lack of b-arrestin recruitment, the PSMa peptides induced an FPR2-dependent ERK1/2 phosphorylation and internalization. Furthermore, structure-activity relationship analysis with PSMa2 derivatives revealed critical roles of the first 3 aa linked to N-fMet as well as the C terminus of PSMa2 in promoting FPR2 to recruit b-arrestin. In summary, our data demonstrate a novel neutrophil activation pattern upon FPR2 sensing of PSMa peptides, signified by the ability to induce increased intracellular Ca 2+ , ERK1/2 phosphorylation, internalization, and NADPH oxidase activity, yet lack of b-arrestin recruitment and neutrophil chemoattraction. These novel features adopted by the PSMa peptides could be of importance for S. aureus virulence and might facilitate identification of new therapeutic strategies for treating S. aureus infections.
GPR84 is a recently de-orphanized member of the G-protein coupled receptor (GPCR) family recognizing medium chain fatty acids, and has been suggested to play important roles in inflammation. Due to the lack of potent and selective GPR84 ligands, the basic knowledge related to GPR84 functions is very limited. In this study, we have characterized the GPR84 activation profile and regulation mechanism in human phagocytes, using two recently developed small molecules that specifically target GPR84 agonistically (ZQ16) and antagonistically (GLPG1205), respectively. Compared to our earlier characterization of the short chain fatty acid receptor FFA2R which is functionally expressed in neutrophils but not in monocytes, GPR84 is expressed in both cell types and in monocyte-derived macrophages. In neutrophils, the GPR84 agonist had an activation profile very similar to that of FFA2R. The GPR84-mediated superoxide release was low in naïve cells, but the response could be significantly primed by TNFα and by the actin cytoskeleton disrupting agent Latrunculin A. Similar to that of FFA2R, a desensitization mechanism bypassing the actin cytoskeleton was utilized by GPR84. All ZQ16-mediated cellular responses were sensitive to GLPG1205, confirming the GPR84-dependency. Finally, our data of in vivo transmigrated tissue neutrophils indicate that both GPR84 and FFA2R are involved in neutrophil recruitment processes in vivo. In summary, we show functional similarities but also some important differences between GPR84 and FFA2R in human phagocytes, thus providing some mechanistic insights into GPR84 regulation in blood neutrophils and cells recruited to an aseptic inflammatory site in vivo.
A nonactivating allosteric modulator of free fatty acid receptor 2 (FFA2R, also called GPCR 43) turns both propionate (an orthosteric FFA2R agonist) and ATP (an agonist for the purinergic P2Y2 receptor), into potent activating ligands that trigger an assembly of the superoxide‐generating neutrophil NADPH oxidase. The ATP‐induced activation requires the participation of FFA2R, and the signaling is biased toward oxidase activation, leaving the ATP‐induced rise in intracellular Ca2+ unaffected. No NADPH oxidase activity was induced by ATP when propionate replaced the allosteric modulator. Signaling downstream of propionate‐activated FFA2Rs was insensitive to Gαq inhibition, but the crosstalk activation involving both FFA2R and P2Y2R relied on Gαq signaling. The receptor crosstalk, by which allosterically modulated FFA2Rs communicate with P2Y2Rs and generate NADPH oxidase activating signals downstream of Gαq, represent a novel mechanism by which GPCR activities can be regulated from inside the plasma membrane. Further, the finding that an allosteric FFA2R modulator sensitizes not only the response induced by orthosteric FFA2R agonists, but also the response induced by ATP (P2Y2R‐specific agonist) and formyl peptide receptor‐specific agonists, violates the receptor restriction characteristics normally defining the selectivity of allosteric GPCR modulators.—Lind, S., Holdfeldt, A., Mårtensson, J., Sundqvist, M., Bjórkman, L., Forsman, H., Dahlgren, C. Functional selective ATP receptor signaling controlled by the free fatty acid receptor 2 through a novel allosteric modulation mechanism. FASEB J. 33, 6887–6903 (2019). http://www.fasebj.org
Activation
as well as recruitment of neutrophils, the most abundant
leukocyte in human blood, to sites of infection/inflammation largely
rely on surface-exposed chemoattractant receptors. These receptors
belong to the family of 7-transmembrane domain receptors also known
as G protein-coupled receptors (GPCRs) due to the fact that part of
the downstream signaling relies on an activation of heterotrimeric
G proteins. The neutrophil GPCRs share significant sequence homologies
but bind many structurally diverse activating (agonistic) and inhibiting
(antagonistic) ligands, ranging from fatty acids to purines, peptides,
and lipopeptides. Recent structural and functional studies of neutrophil
receptors have generated important information on GPCR biology in
general; this knowledge aids in the overall understanding of general
pharmacological principles, governing regulation of neutrophil function
and inflammatory processes, including novel leukocyte receptor activities
related to ligand recognition, biased/functional selective signaling,
allosteric modulation, desensitization mechanisms and reactivation,
and communication (cross-talk) between GPCRs. This review summarizes
the recent discoveries and pharmacological hallmarks with focus on
neutrophil GPCRs. In addition, unmet challenges are dealt with, including
recognition by the receptors of diverse ligands and how biased signaling
mediates different biological effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.